Featured Question

How should we interpret and apply to practice the new data reported at ASCO 2014, focusing on initiating chemotherapy along with hormone therapy in men with newly metastatic prostate cancer? For which patients should or should we not use this treatment approach?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

10-17-2014

Challenging Cases in Advanced Prostate Cancer: Expert Guidance on Selection and Sequencing of the Latest Therapies

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana

10-02-2014

Latest Imaging Tools for Assessing the Disease Course of Patients With Multiple Sclerosis

Course Director
Matilde Inglese, MD, PhD
Icahn School of Medicine at
Mount Sinai
New York, New York

09-19-2014

Assessing the Evolving Therapeutic Landscape in Advanced Prostate Cancer: Where Do We Stand?

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana

09-04-2014

Practical Considerations in the Management of Patients With Ulcerative Colitis

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

09-02-2014

Current and Emerging Imaging Techniques in Multiple Sclerosis: Where Are We Now and Where Are We Going?

Course Director
Robert Naismith, MD
Washington University
School of Medicine
St. Louis, Missouri

08-04-2014

The Expanding Role of Biologic Therapies for Ulcerative Colitis: Assessing the State of the Science and Implications for Practice

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

03-15-2013

Challenging Cases in Multiple Sclerosis

Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York